RANGE INTERNATIONAL

ASX Announcement

24 April 2026

Notice of Annual General Meeting and Proxy Form

Range International Limited (ASX:RAN) (the Company or Range) advises that the 2026 Annual General Meeting will be held at 11:30am (AEST) on Monday, 25 May 2026 at the offices of Automatic Group, Level 5, 126 Phillip Street, Sydney NSW 2000.

In accordance with Listing Rule 3.17, attached are the following documents:

Letter to Shareholders;
Notice of Annual General Meeting; and
Proxy Form.

This announcement has been approved by the Board of the Company.

Richard Jenkins
Executive Chairman
[email protected]
+61 417 242 946

David Hwang
Company Secretary
[email protected]
+61 433 292 290

About Range International:

Range is a manufacturer of plastic pallets. Our ThermoFusion™ technology allows Range to make 'zero waste', 100% upcycled plastic pallets. Range currently has production lines operating in its East Java factory in Indonesia and sells its pallets under the brand Re>Pal™, supplying pallets into Indonesia and across Asia Pacific.

RANGE INTERNATIONAL LTD ACN 611 998 200 | Level 5, 137-139 Bathurst St Sydney, NSW 2000 | www.rangeinternational.com

RANGE INTERNATIONAL

24 April 2026

2026 Annual General Meeting

Dear Shareholder,

Range International Limited ACN 611 998 200 (ASX: RAN) (the Company or Range) advises the 2026 Annual General Meeting will be held in person at Automic Group, Level 5, 126 Phillip Street, Sydney, New South Wales on Monday, 25 May 2026 at 11:30am (AEST) (AGM or the Meeting).

Notice of Meeting

The Notice of Meeting and Explanatory Statement (the Notice) for the Meeting is available online and can be viewed and downloaded by shareholders of the Company (the Shareholders) from the Company's website at www.rangeinternational.com or the Company's ASX market announcements platform at www.asx.com.au (ASX: RAN).

In accordance with Part 1.2AA of the Corporations Act 2001 (Cth) (the Act), the Notice will be made available to Shareholders electronically. A physical copy of the Notice will only be sent to Shareholders who have previously elected to receive communications from the Company in hard copy.

Voting by Proxy

Online Use your computer or smartphone to appoint a proxy at https://investor.automic.com.au/#/loginsah or scan the QR code below using your smartphone. Login & click on ‘Meetings’. Use the Holder Number as shown at the top of your Proxy Form.
Post Automic, GPO Box 5193, Sydney NSW 2001
By Hand Automic, Level 5, 126 Phillip Street, Sydney NSW 2000
By Email Complete the Proxy Form and email it to: [email protected]

For further information on the online proxy lodgment process, or if you require a hard copy Proxy Form, please contact the Company's Share Registry, Automic Registry Services (Automic), at [email protected] or via phone on 1300 288 664 (within Australia) or +61 2 9698 5414 (overseas).

Shareholder queries in relation to the Meeting

Shareholders can contact the Company Secretary with any questions prior to the Meeting via email at [email protected].

We look forward to your participation at the Annual General Meeting.

Yours faithfully,

David Hwang

Company Secretary

RANGE INTERNATIONAL LTD ACN 611 998 200 | Level 5, 137-139 Bathurst St, Sydney, NSW 2000 | www.rangeinternational.com

Notice of

Annual General Meeting

Explanatory Statement | Proxy Form

RANGE
INTERNATIONAL

Range International Limited
ACN 611 998 200

Notice is given that the Annual General Meeting (AGM or the Meeting) of Shareholders of Range International Limited (ASX: RAN) (Range or the Company) will be held as follows:

Date	Monday, 25 May 2026
Time	11:30am (AEST)
Venue Location	Automic Group, Level 5, 126 Phillip Street, Sydney NSW 2000

This Notice of Meeting should be read in its entirety. If Shareholders are uncertain about how to vote, they are encouraged to consult their professional advisors before casting their vote.

The accompanying Explanatory Statement provides further details regarding the matters to be addressed at the Meeting. This Notice of Meeting comprises the Explanatory Statement and the Proxy Form.

In accordance with Regulation 7.11.37 of the Corporations Regulations 2001 (Cth), the Directors have determined that those eligible to vote at the Annual General Meeting will be Shareholders registered as of 7:00pm (AEST) on Friday, 22 May 2026.

Definitions of terms and abbreviations used in this Notice of Meeting and the Explanatory Statement can be found in the Glossary.

Meeting Information

Important Information for Shareholders about the Company's 2026 AGM

This Notice of Meeting (the Notice) is given based on circumstances as at Friday, 24 April 2026. Should circumstances change, the Company will make an announcement on the ASX market announcements platform and on the Company's website at https://www.rangeinternational.com/other-information/.

Shareholders are urged to monitor each for any changes leading up to the AGM date.

Venue and Voting Information

The Annual General Meeting of Shareholders to which this Notice of Meeting relates will be held at 11:30am (AEST) on Monday, 25 May 2026 at Automic Group, Level 5, 126 Phillip Street, Sydney NSW 2000.

Your vote is important

The business of the Meeting affects your shareholding and your vote is important.

Voting in person

To vote in person, attend the Meeting on the date and at the location set out above.

Voting by proxy

To vote by proxy, please use one of the methods outlined in the table below.

Shareholders will need their holder number (Securityholder Reference Number (SRN)) or Holder Identification Number (HIN)) as shown on the front of the Proxy Form.

Your Proxy instruction must be received not later than 48 hours before the commencement of the Meeting.

Proxy Forms received later than this time will be invalid.

Online

Lodge the Proxy Form online at https://investor.automic.com.au/#/loginsah by following the instructions:

Click on 'View Meetings' – 'Vote'. To use the online lodgement facility, Shareholders will need their holder number (Securityholder Reference Number (SRN) or Holder Identification Number (HIN)) as shown on the front of the Proxy Form.

For further information on the online proxy lodgement process please see the Online Proxy Lodgement Guide at https://www.automicgroup.com.au/virtual-agms/.

By Post

Automic, GPO Box 5193, Sydney NSW 2001

By Hand

Automic, Level 5, 126 Phillip Street, Sydney NSW 2000

By Email

Complete the enclosed Proxy Form and email it to: [email protected]

Questions to the Board and Management

Shareholders will have a reasonable opportunity at the Annual General Meeting to ask questions relating to the management of the Company and any items of business set out in this Notice of Meeting.

To assist with the efficient conduct of the AGM, Shareholders are also invited to submit written questions in advance of the meeting. These may be directed to the Board, the Company's management, or relate to any agenda items.

Please send written questions to the Company Secretary at: [email protected].

Questions must be received by Monday, 18 May 2026 to ensure they can be addressed at the Meeting. Similar questions may be grouped and answered together.

Power of Attorney

If the proxy form is signed under a power of attorney on behalf of a Shareholder, then the attorney must make sure that either the original power of attorney or a certified copy is sent with the proxy form, unless the power of attorney has already provided it to the Share Registry.

Corporate Representatives

If a representative of a corporate shareholder or a corporate proxy will be attending the Meeting, the representative should bring to the Meeting adequate evidence of their appointment, unless this has previously been provided to the Share Registry.

BUSINESS OF THE MEETING

Financial Statements and Reports

"To receive and to consider the Annual Financial Report of the Company for the financial year ended 31 December 2025 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year."

Note: This item of ordinary business is for discussion only and is not a resolution.

Pursuant to the Corporations Act, Shareholders will be given a reasonable opportunity at the Meeting to ask questions about, or make comments in relation to, each of the reports during consideration of these items.

Resolution 1 – Adoption of Remuneration Report

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, for the purpose of Section 250R(2) of the Corporations Act and for all other purposes, approval is given for the adoption of the Remuneration Report as contained in the Company's Annual Financial Report for the financial year ended 31 December 2025."

Note: The vote on this Resolution is advisory only and does not bind the Directors or the Company.

Resolution 2 – Election of Mark Skipper as Director

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, Mark Skipper, a Director appointed as an additional Director and holding office until the next general meeting of the Company after their appointment in accordance with the Company's Constitution and ASX Listing Rule 14.4, be elected as a Director of the Company, effective immediately."

Resolution 3 – Re-election of Richard Jenkins as Director

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That Richard Jenkins, a Director who retires by rotation in accordance with the Company's Constitution and ASX Listing Rule 14.5 and being eligible offers themselves for re-election as a Director of the Company, effective immediately."

Resolution 4 – Re-election of Christopher Fong as Director

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That Christopher Fong, a Director who retires by rotation in accordance with the Company's Constitution and ASX Listing Rule 14.5 and being eligible offers themselves for re-election as a Director of the Company, effective immediately."

Resolution 5 – ASX Listing Rule 7.1A Approval of Future Issue of Securities (Additional 10% Placement Capacity)

To consider and, if thought fit, to pass the following resolution as a Special Resolution:

"That, for the purposes of ASX listing Rule 7.1A and for all other purposes, the Shareholders approve the issue of equity securities up to 10% of the issued capital of the Company (at the time of issue)

calculated in accordance with the formula prescribed in ASX listing Rule 7.1A.2 and otherwise on the terms and conditions set out in the Explanatory Statement which accompanies and forms part of this Notice of Meeting."

Resolutions 6 – 9: Issue of Fully Paid Ordinary Shares in lieu of Director Fees

Resolution 6 – Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Richard Jenkins, Executive Chair of the Company

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, for the purposes of ASX Listing Rule 10.11 and for all other purposes, the Shareholders of the Company approve the issue and allotment of up to 48,324,743 Fully Paid Ordinary Shares (pre-consolidation) to Richard Jenkins (or his nominee), Executive Chair of the Company, in lieu of cash director fees for the period up to 31 December 2026 and otherwise on the terms and conditions set out in the Explanatory Statement which accompanies and forms part of this Notice of Meeting."

Resolution 7 – Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Christopher Fong, Executive Director of the Company

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, for the purposes of ASX Listing Rule 10.11 and for all other purposes, the Shareholders of the Company approve the issue and allotment of up to 16,108,248 Fully Paid Ordinary Shares (pre-consolidation) to Christopher Fong (or his nominee), Executive Director of the Company, in lieu of cash director fees for the period up to 31 December 2026 and otherwise on the terms and conditions set out in the Explanatory Statement which accompanies and forms part of this Notice of Meeting."

Resolution 8 – Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Neil Macdonald, Non-Executive Director of the Company

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, for the purposes of ASX Listing Rule 10.11 and for all other purposes, the Shareholders of the Company approve the issue and allotment of up to 9,664,949 Fully Paid Ordinary Shares (pre-consolidation) to Neil Macdonald (or his nominee), Non-Executive Director of the Company, in lieu of cash director fees for the period up to 31 December 2026 and otherwise on the terms and conditions set out in the Explanatory Statement which accompanies and forms part of this Notice of Meeting."

Resolution 9 – Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Mark Skipper, Non-Executive Director of the Company

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, for the purposes of ASX Listing Rule 10.11 and for all other purposes, the Shareholders of the Company approve the issue and allotment of up to 9,664,949 Fully Paid Ordinary Shares (pre-consolidation) to Mark Skipper (or his nominee), Non-Executive Director of the Company, in lieu of cash director fees for the period up to 31 December 2026 and otherwise on the terms and conditions set out in the Explanatory Statement which accompanies and forms part of this Notice of Meeting."

Resolution 10 – Approval of Issue of Fully Paid Ordinary Shares in lieu of Salary to Russell Kennett, Chief Executive Officer of the Company

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, for the purposes of ASX Listing Rule 7.1 and for all other purposes, the Shareholders of the Company approve the issue and allotment of up to 9,664,949 Fully Paid Ordinary Shares (pre-consolidation) to Russell Kennett (or his nominee), Chief Executive Officer of the Company, in lieu of salary for the period up to 31 December 2026 and otherwise on the terms and conditions set out in the Explanatory Statement which accompanies and forms part of this Notice of Meeting."

Resolutions 11–14: Issue of Incentive Securities to Related Parties

Resolution 11 - Approval of Issue of Incentive Securities to Richard Jenkins – Executive Chair of the Company, under the Employee Incentive Plan

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, the Shareholders of the Company approve the issue and allotment of 18,000,000 Share Appreciation Rights (pre-consolidation) under the Employee Incentive Plan to Richard Jenkins (or his nominee), Executive Chair of the Company and otherwise on the terms and conditions set out in the Explanatory Statement which accompanies and forms part of this Notice of Meeting."

Resolution 12 – Approval of Issue of Incentive Securities to Christopher Fong – Executive Director of the Company, under the Employee Incentive Plan

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, the Shareholders of the Company approve the issue and allotment of 5,000,000 Share Appreciation Rights (pre-consolidation) under the Employee Incentive Plan to Christopher Fong (or his nominee), Executive Director of the Company and otherwise on the terms and conditions set out in the Explanatory Statement which accompanies and forms part of this Notice of Meeting."

Resolution 13 – Approval of Issue of Incentive Securities to Neil Macdonald – Non-Executive Director of the Company, under the Employee Incentive Plan

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, the Shareholders of the Company approve the issue and allotment of 5,000,000 Share Appreciation Rights (pre-consolidation) under the Employee Incentive Plan to Neil Macdonald (or his nominee), Non-Executive Director of the Company and otherwise on the terms and conditions set out in the Explanatory Statement which accompanies and forms part of this Notice of Meeting."

Resolution 14 – Approval of Issue of Incentive Securities to Mark Skipper – Non-Executive Director of the Company, under the Employee Incentive Plan

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, the Shareholders of the Company approve the issue and allotment of 5,000,000 Share Appreciation Rights (pre-consolidation) under the Employee Incentive Plan to Mark Skipper (or his nominee), Non-Executive Director of the Company and otherwise on the terms and conditions set out in the Explanatory Statement which accompanies and forms part of this Notice of Meeting."

Resolution 15 – Consolidation of Capital

To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution:

"That, for the purposes of section 254H of the Corporations Act and for all other purposes, the issued capital of the Company be consolidated on the terms and conditions set out in the Explanatory Statement and on the basis that:

every hundred (100) Shares be consolidated into one (1) Share;
all unquoted securities be consolidated in accordance with Listing Rule 7.22; and
and where this consolidation results in a fraction of a Security being held, the Company be authorised to round that fraction up to the nearest whole Security."

Voting Exclusion and Prohibition Statements

Resolution(s) Affected	Voting Exclusion and/or Prohibition Statement
Resolution 1 – Adoption of Remuneration Report	Voting Exclusion Statement
In accordance with the Corporations Act, the Company will disregard any votes cast on Resolution 1 by or on behalf of a member of the Company’s key management personnel (including the Directors), whose remuneration details are included in the Remuneration Report (KMP), or any of that person’s Closely Related Parties (such as close family members and any controlled companies of those persons) (collectively referred to as Restricted Voter). However, the Company need not disregard a vote if:

Resolution(s) Affected

Voting Exclusion and/or Prohibition Statement

Resolution 1 – Adoption of Remuneration Report

Voting Exclusion Statement

In accordance with the Corporations Act, the Company will disregard any votes cast on Resolution 1 by or on behalf of a member of the Company’s key management personnel (including the Directors), whose remuneration details are included in the Remuneration Report (KMP), or any of that person’s Closely Related Parties (such as close family members and any controlled companies of those persons) (collectively referred to as Restricted Voter). However, the Company need not disregard a vote if:

(a) it is cast by a person as a proxy appointed in writing that specifies how the proxy is to vote on Resolution 1; and
(b) it is not cast on behalf of a Restricted Voter.

If you appoint the person chairing the Meeting (Chair) and you are not a Restricted Voter, by submitting the Proxy Form you authorise the person chairing the Meeting to exercise the proxy even though it is connected directly or indirectly with the remuneration of a KMP, and you will be taken to have directed the Chair to vote in accordance with their stated intention to vote in favour of Resolution 1. If you do not want your vote exercised in favour of Resolution 1, you should direct the person chairing the Meeting to vote “against”, or to abstain from voting on, this Resolution. |
| Resolution 5 – ASX Listing Rule 7.1A Approval of Future Issue of Securities (Additional 10% Placement Capacity) | Voting Exclusion Statement
The Company will disregard any votes cast in favour of Resolution 5 by or on behalf of:

(a) a person who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder of ordinary securities in the Company); or
(b) an Associate of that person or those persons.

However, this does not apply to a vote cast in favour of Resolution 5 by:

(a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or
(b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:
• the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and
• the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way. |

Resolutions 6, 7, 8 and 9 - Issue of Fully Paid Ordinary Shares in lieu of Director Fees

Resolution 10 – Approval of Issue of Fully Paid Ordinary Shares in lieu of Salary to Russell Kennett, Chief Executive Officer of the Company

Voting Exclusion Statement

The Company will disregard any votes cast in favour of Resolutions 6, 7, 8 and 9 by or on behalf of:

(a) persons who are expected to receive the securities as a result of the proposed issue;
(b) persons who will obtain a material benefit as a result of the issue of securities (except a benefit solely by reason of being a holder of the ordinary securities in the Company); or
(c) an Associate of those persons or those persons described in (a) or (b).

However, this does not apply to a vote cast in favour of Resolutions 6, 7, 8 and 9 by:

(a) persons as proxy or attorney for a person who is entitled to vote on the Resolutions, in accordance with directions given to the proxy or attorney to vote on the Resolutions in that way; or
(b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolutions, in accordance with a direction given to the Chair to vote on the Resolutions as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolutions; and
the holder votes on the Resolutions in accordance with directions given by the beneficiary to the holder to vote in that way.

Voting Exclusion Statement

The Company will disregard any votes cast in favour of Resolution 10 by or on behalf of:

(a) a person who is expected to participate in, or who will obtain a material benefit as a result of the issue of securities (except a benefit solely by reason of being a holder of the ordinary securities in the Company); or
(b) an Associate of those persons.

However, this does not apply to a vote cast in favour of Resolution 10 by:

a) persons as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with directions given to the proxy or attorney to vote on the Resolution in that way; or
b) the Chair of the Meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolutions; and

Resolutions 11, 12, 13 and 14 – Issue of Incentive Securities to Related Parties

the holder votes on the Resolutions in accordance with directions given by the beneficiary to the holder to vote in that way.

Voting Exclusion Statement

The Company will disregard any votes cast in favour of Resolutions 11, 12, 13 and 14 by or on behalf of:

(a) a person referred to in rule 10.14.1, 10.14.2 or 10.14.3 who is eligible to participate in the Employee Incentive Plan; or ;
(b) an Associate of that person or those persons.

However, this does not apply to a vote cast in favour of Resolutions 11, 12, 13 and 14 by:

(a) a person as proxy or attorney for persons who are entitled to vote on the Resolutions, in accordance with direction given to the proxy or attorney to vote on the Resolutions in that way; or
(b) the Chair of the Meeting as proxy or attorney for persons who are entitled to vote on the Resolutions, in accordance with a direction given to the Chair to vote on the Resolutions as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of the beneficiaries provided the following conditions are met:

the beneficiaries provide written confirmation to the holder that the beneficiaries are not excluded from voting, and are not an associates of a person excluded from voting, on the Resolution; and
the holder votes on the Resolution in accordance with directions given by the beneficiaries to the holder to vote in that way.

Voting Prohibition Statement

In accordance with section 250BD of the Corporations Act, a person appointed as a proxy must not vote on the basis of that appointment, on Resolution 11, 12, 13 and 14 if:

(a) the proxy is either:

a member of the Company's Key Management Personnel; or
a Closely Related Party of a member of the Company's Key Management Personnel; and

(b) the appointment does not specify the way the proxy is to vote on the resolution. However, the above prohibition does not apply if:

the proxy is the Chair of the Meeting; and
the appointment expressly authorises the Chair to exercise the proxy even if the Resolution is connected directly or indirectly with remuneration of a member of the Company's Key Management Personnel.

BY ORDER OF THE BOARD

Euh Hwang
Company Secretary

Explanatory Statement

This Explanatory Statement has been prepared for the information of the Shareholders in connection with the business to be conducted at the Annual General Meeting to be held at 11:30am (AEST) on Monday, 25 May 2026 at Automic Group, Level 5, 126 Phillip Street, Sydney NSW 2000.

The purpose of this Explanatory Statement is to provide information which the Directors believe to be material to Shareholders in deciding whether or not to pass the Resolutions in the Notice of Meeting.

If you are in any doubt about what to do in relation to the Resolutions contemplated in the Notice of Meeting and this Explanatory Statement, it is recommended that you seek advice from an accountant, solicitor or other professional advisor.

Basis of Securities Numbers

Unless otherwise stated, all references in this Notice of Meeting to the number of Shares, Share Appreciation Rights are expressed on a pre-consolidation basis.

If Resolution 15 (Share Consolidation) is approved by Shareholders, the number of securities to be issued or the subject of any approval under this Notice will be adjusted in accordance with the consolidation ratio set out in Resolution 15, with any resulting fractional entitlements rounded in a manner determined by the Board (subject to ASX Listing Rules and Corporations Act 2001 (Cth)).

Business of the Meeting

Financial Statements and Reports

In accordance with the Constitution and the Corporations Act, the business of the Annual General Meeting will include receipt and consideration of the Annual Financial Report of the Company for the financial year ended 31 December 2025 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report.

In accordance with the amendments to the Corporations Act, the Company is no longer required to provide a hard copy of the Company's Annual Financial Report to Shareholders unless a Shareholder has specifically elected to receive a printed copy.

Whilst the Company will not provide a hard copy of the Company's Annual Financial Report unless specifically requested to do so, Shareholders may view the Company Annual Financial Report on its website at https://www.rangeinternational.com/financial-reports/.

No resolution is required for this item, but Shareholders will be given the opportunity to ask questions and to make comments on the management and performance of the Company.

The Company's auditor will be present at the Meeting. During the discussion of this item, the auditor will be available to answer questions on the:

Conduct of the audit;
Preparation and content of the Auditor's Report;
Accounting policies adopted by the Company in relation to the preparation of the financial statements; and
Independence of the auditor in relation to the conduct of the audit.

Written Questions to the Auditor

If you would like to submit a written question about the content of the Auditor's Report or the conduct of the audit of the Annual Financial Report of the Company's auditor, please send your question to the Company Secretary. A list of qualifying questions will be made available at the Meeting.

Please note that all written questions must be received at least five Business Days before the Meeting, which is by Monday, 18 May 2026.

Resolution 1 - Adoption of Remuneration Report

In accordance with section 250R(2) of the Corporations Act, the Company is required to present to its Shareholders the Remuneration Report as disclosed in the Company's Annual Financial Report.

The vote on the Resolution is advisory only and does not bind the Directors or the Company. The Remuneration Report is set out in the Company's Annual Financial Report and is also available on the Company's website at https://www.rangeinternational.com/financial-reports/.

However, if at least 25% of the votes cast are against the adoption of the Remuneration Report at the Meeting (subject of this Notice of Meeting), and then again at the 2027 Annual General Meeting (2027 AGM), the Company will be required to put to the vote a resolution (Spill Resolution) at the 2027 AGM to approve the calling of a further meeting (Spill Meeting). If more than 50% of Shareholders vote in favour of the Spill Resolution, the Company must convene the Spill Meeting within 90 days of the 2027 AGM. All of the Directors who were in office when the 2027 Directors' Report was approved, other than the Managing Director, will (if desired) need to stand for re-election at the Spill Meeting.

The Remuneration Report explains the Board's policies in relation to the nature and level of remuneration paid to KMPs (including Directors) and sets out remuneration details, service agreements and the details of any share-based compensation.

Voting Exclusion

A voting exclusion applies to this Resolution and is set out in the Voting Exclusion and Prohibition Statements.

Directors' Recommendation

The Board is not making a recommendation for this Resolution.

Chair's Intention

The Chair intends to vote all undirected proxies in favour of this Resolution.

Resolution 2 - Election of Mark Skipper as Director

The Constitution allows the Directors to appoint at any time a person to be a Director either to fill a casual vacancy or as an addition to the existing Directors, but only where the total number of Directors does not at any time exceed the maximum number specified by the Constitution.

Pursuant to the Constitution and Listing Rule 14.4, any Director so appointed holds office only until the next annual general meeting and is then eligible for election by Shareholders but shall not be taken into account in determining the Directors who are to retire by rotation (if any) at that meeting.

Mark Skipper was appointed as a Director by the Company's board of Directors on 29 September 2025. Subject to the Constitution, any Director so appointed automatically retires at the next annual general meeting and is eligible for election by that general meeting. Accordingly, Mark Skipper will retire at the 2026 AGM in compliance with Listing Rule 14.4 and clause 3.3 of the Constitution and stand for election in 2026.

Under this Resolution Mark Skipper will retire, and being eligible, seeks election as a Director of the Company at this AGM.

Biography of Mark Skipper

Mark Skipper has extensive board, executive, sales and marketing experience across manufacturing, supply chain, logistics, information technology and medical devices.

He served for 25 years as a director of Bronson and Jacobs, a top 150 Australian private company supplying ingredients to the food, beverage, personal care, pharmaceutical, cosmetic, health and agricultural industries, with operations across Australia, Asia, Europe, New Zealand and the United States. Mark has also held senior roles in the information technology sector across Australia and Asia

Pacific, spanning hardware, ERP, cloud and cyber security, as well as the medical device industry. He was a Director and Chairman of the Australasian Supply Chain & Logistics Association

Directors' Recommendation

Mark Skipper has an interest in this Resolution and therefore does not make a recommendation.

The other Directors recommend a vote in favour of this Resolution.

Chair's Intention

The Chair intends to vote all undirected proxies in favour of this Resolution.

Resolution 3 – Re-election of Richard Jenkins as Director

Pursuant to the Constitution and Listing Rule 14.5, any Director so appointed holds office only until the next annual general meeting and is then eligible for election by Shareholders but shall not be taken into account in determining the Directors who are to retire by rotation (if any) at that meeting.

Richard Jenkins was appointed a Director of the Company on 5 December 2019 and was last re-elected as a Director at the Annual General Meeting held on 30 May 2023.

Under this Resolution, Richard Jenkins has elected to retire by rotation, and being eligible, seeks re-election as a Director of the Company at this AGM.

Biography of Richard Jenkins

Richard Jenkins has extensive experience in financial markets, funds management and corporate advisory services. He spent more than two decades at Hill Samuel and Macquarie Bank in senior trading and executive roles, including Head of the Equities Group, and joined the Executive Committee of Macquarie Bank in 1992. He is the founder and director of Shell Cove Capital Management, which has held an Australian Financial Services License since 2004. Richard joined the Board of Range International in 2019. In 2026, he was appointed a Director of Cardio Resus Limited, a manufacturing business developing a miniaturized automated external defibrillator.

Directors' Recommendation

Richard Jenkins has an interest in this Resolution and therefore does not make a recommendation.

The other Directors recommend a vote in favour of this Resolution.

Chair's Intention

The Chair intends to vote all undirected proxies in favour of this Resolution.

Resolution 4 – Re-election of Christopher Fong as Director

Christopher Fong was appointed a Director of the Company on 5 December 2019 and was last re-elected as a Director at the Annual General Meeting held on 12 May 2021.

Under this Resolution, Christopher Fong has elected to retire by rotation, and being eligible, seeks re-election as a Director of the Company at this AGM.

Biography of Christopher Fong

Chris Fong has extensive business experience in Indonesia, built over more than 30 years of working across communications, corporate advisory and strategic project management. In 1992, he was appointed Country Manager (Indonesia) for media services group YRN Communications, and later became Vice President, Marketing, overseeing offices in six countries. In 1998, he became a managing partner in a Singapore-based communications business that experienced significant growth associated with the Indonesian market.

Over the following decade, Chris managed a diverse range of projects spanning debt restructuring, crisis management, consumer and brand development, and democratic and environmental reform for multinational corporations, family-controlled conglomerates and government.

Directors' Recommendation

Christopher Fong has an interest in this Resolution and therefore does not make a recommendation.

The other Directors recommend a vote in favour of this Resolution.

Chair's Intention

The Chair intends to vote all undirected proxies in favour of this Resolution.

Resolution 5 – ASX Listing Rule 7.1A Approval of Future Issue of Securities (Additional 10% Placement Capacity)

Under Listing Rule 7.1A, however, an eligible entity can seek approval from its members, by way of a special resolution passed at its annual general meeting, to add an additional 10% capacity. An eligible entity for the purposes of Listing Rule 7.1A is an entity that is not included in the S&P/ASX 300 Index and has a market capitalisation less than the amount prescribed by ASX (currently $300 million).

As of the date of this Notice of Meeting, the Company has a market capitalisation of approximately $3.57 million and therefore is an eligible entity. If at the time of the Meeting the Company is no longer an eligible entity this Resolution will be withdrawn.

This Resolution seeks Shareholder approval by way of a special resolution for the Company to have the additional 10% capacity provided for in Listing Rule 7.1A to issue equity securities without Shareholder approval.

If this Resolution is passed, the Company will be able to issue equity securities up to the combined 25% limit in Listing Rules 7.1 and 7.1A without any further Shareholder approval.

If this Resolution is not passed, the Company will not be able to access the additional 10% capacity to issue equity securities without Shareholder approval provided for in Listing Rule 7.1A and will remain subject to the 15% limit on issuing equity securities without Shareholder approval set out in Listing Rule 7.1.

Information Required by ASX Listing Rule 7.3A

The following information is provided to Shareholders for the purposes of Listing Rule 7.3A.

Period for which the approval will be valid

An approval under this Listing Rule 7.1A commences on the date of the annual general meeting at which the approval is obtained and expires on the first to occur of the following:

(a) the date which is 12 months after the date of the annual general meeting at which the approval is obtained;

(b) the time and date of the entity's next annual general meeting; and

(c) the time and date on which Shareholders approve a transaction under Listing Rule 11.1.2 (a significant change to the nature or scale of activities) or 11.2 (disposal of main undertaking).

Minimum price at which the equity securities may be issued under Listing Rule 7.1A

Any equity securities issued under Listing Rule 7.1A.2 must be an existing quoted class of the Company's equity securities and issued for cash consideration.

The issue price per equity security must not be less than 75% of the volume weighted average market price of the equity securities in that class, calculated over 15 Trading Days on which trades in that class were recorded immediately before:

(a) the date on which the price at which the equity securities are to be issued is agreed by the Company and the recipient of the equity securities; and
(b) if the equity securities are not issued within 10 trading days of the date in paragraph (a), the date on which the equity securities are issued.

Purposes for which the funds raised by an issue of equity securities under Listing Rule 7.1A may be used

As noted above, any equity securities issued under Listing Rule 7.1A.2 must be issued for cash consideration. Accordingly, every issue of equity securities under Listing Rule 7.1A.2 will have an accompanying proposed use of funds at the time of issue.

As at the date of this Notice, the Company has not formed an intention to offer any equity securities under Listing Rule 7.1A during the Listing Rule 7.1A mandate period, if Shareholders approve this Resolution. However, if Shareholders approve this Resolution and the Company does raise funds from the issue of equity securities under Listing Rule 7.1A, based on the Company's existing plans, the Company considers that the funds may be used for the following purposes:

(a) to further develop the Company's business;
(b) to be applied to the Company's working capital requirements; and
(c) to pay service providers or consultants of the Company.

Risk of economic and voting dilution to existing ordinary Securityholders

If this Resolution is approved, and the Company issues equity securities under Listing Rule 7.1A, the existing Shareholders' economic and voting power in the Company will be diluted.

There is a risk that:

(a) the market price for the Company's equity securities in that class may be significantly lower on the issue date than on the date of the approval under Listing Rule 7.1A; and
(b) the equity securities may be issued at a price that is at a discount (as described above) to the market price for the Company's equity securities on the issue date;

which may have an effect on the amount of funds raised by the issue of equity securities under Listing Rule 7.1A.

The table below shows the potential dilution of existing Securityholders on the basis of 3 different assumed issue prices and values for the variable "A" in the formula in rule 7.1A.2:

Variable “A” ASX Listing Rule 7.1A.2		Potential Dilution and Funds Raised
		$0.0015
50% decrease in
issue price	$0.003
issue price^{(b)}	$0.006
100% increase in
issue price
“A” is the number of shares on issue,^{(c)} being	10% voting dilution^{(c)}	178,511,382	178,511,382	178,511,382
1,785,113,821 Shares	Funds raised	$267,767	$535,534	$1,071,068
“A” is a 50% increase in shares on issue, being	10% voting dilution^{(c)}	267,767,073	267,767,073	267,767,073
2,677,670,732 Shares	Funds raised	$401,651	$803,301	$1,606,602
“A” is a 100% increase in shares on issue, being	10% voting dilution^{(c)}	357,022,764	357,022,764	357,022,764
3,570,227,642 Shares	Funds raised	$535,534	$1,071,068	$2,142,137

Notes:

(a) The total number of fully paid ordinary Shares on issue as at 1 April 2026 is 1,785,113,821.

(b) Based on the closing price of the Company’s Shares on ASX as at 1 April 2026, being $0.003 per Share.

(c) The table assumes that the Company issues the maximum number of ordinary Shares available to be issued under Listing Rule 7.1A.

(d) The table does not show an example of dilution that may be caused to a particular Shareholder by reason of issues of equity securities under Listing Rule 7.1A based on that Shareholder’s holding at the date of this Explanatory Statement.

(e) The table shows the effect of an issue of equity securities under Listing Rule 7.1A only, not under the Company’s 15% placement capacity under Listing Rule 7.1

Allocation policy for issues under Listing Rule 7.1A

The Company’s allocation policy and the identity of the allottees of equity securities under Listing Rule 7.1A will depend on several factors, including:

(a) the Company’s intentions in relation to the possible issue of equity securities (for cash consideration) during the Listing Rule 7.1A mandate period;

(b) the structure and timeframe of the capital raising opportunities available to the Company and any alternative methods for raising funds that are available to the Company (such as a pro rata offer or an offer under a share purchase plan);

(d) the Company’s financial position and the likely future capital requirements; and

(e) advice from the Company’s corporate or financial advisors.

Based on the Company’s historical cashflow reports and capital raising activities in the past 12 months, the Company considers that it may raise funds during the Listing Rule 7.1A mandate period, although this cannot be guaranteed. As of the date of this Notice, no specific intention to issue equity securities in relation to any parties, investors or existing Securityholders has been formed. In addition, no intentions have been formed in relation to the possible number of issues, or the time frame in which the issues could be made. Subject to the requirements of the Listing Rules and the Corporations Act, the board of Directors reserves the right to determine at the time of any issue of equity securities under Listing Rule 7.1A, the allocation policy that the Company will adopt for that issue.

When and if the determination is made to proceed with an issue of equity securities during the Listing Rule 7.1A mandate period, details regarding the allottees and purposes of issue will be disclosed pursuant to the Company's obligations under Listing Rules 3.10.3 and 7.1A.4.

Offers made under Listing Rule 7.1A may be made to parties (excluding any related parties) including professional and sophisticated investors, existing Shareholders of the Company, clients of Australian Financial Services Licence holders and/or their nominees, or any other person to whom the Company is able to make an offer of equity securities.

Issue or agreement to issue equity securities under Listing Rule 7.1A in the 12 months prior to the AGM

The Company previously obtained shareholder approval under Listing Rule 7.1A at the 2025 AGM. However, the Company has not issued or agreed to issue equity securities under Listing Rule 7.1A.2 in the 12 months preceding the AGM.

This Resolution is a Special Resolution. For a Special Resolution to be passed, at least 75% of the votes validly cast on the resolution by Shareholders (by number of ordinary shares) must be in favour of this Resolution.

Voting Exclusion

A voting exclusion applies to this Resolution and is set out in the Voting Exclusion and Prohibition Statements.

Directors' Recommendation

The Directors recommend a vote in favour of this Resolution.

Chair's Intention

The Chair intends to vote all undirected proxies in favour of this Resolution.

Resolutions 6, 7, 8 and 9 – Issue of Fully Paid Ordinary Shares in lieu of Director Fees

Resolutions 6, 7, 8 and 9 seek Shareholder approval to issue and allot a total of 83,762,889 Fully Paid Ordinary Shares at a deemed issue price of A$0.003104 per Share to Directors (or their nominees) in lieu of cash Director fees for the period that they have served as a Director from 31 January 2026 until 31 December 2026 (CY26 Fee Shares).

Further details in respect of the intended issue of CY26 Fee Shares to the Directors are set out in the table below:

Allottee (or their nominee)	Annual Remuneration as of the date of this Notice	Remuneration that will be paid in CY26 Fee Shares	Grant of Fully Paid Ordinary Shares for which Shareholder approval is being sought
Richard Jenkins	A$150,000.00	A$150,000.00	48,324,743
Christopher Fong	A$50,000.00	A$50,000.00	16,108,248
Neil Macdonald	A$30,000.00	A$30,000.00	9,664,949
Mark Skipper	A$30,000.00	A$30,000.00	9,664,949
Total	A$260,000.00	A$260,000.00	83,762,889

Listing Rule 10.11

ASX Listing Rule 10.11 requires a listed company to obtain shareholder approval (unless one of the exceptions in ASX Listing Rule 10.12 applies) for the issue of securities to certain persons, including:

(a) a related party;
(b) a person who is, or was at any time in the 6 months before the issue of agreement, a substantial (30%+) holder in the Company;

(c) a person who is, or was at any time in the 6 months before the issue or agreement, a substantial (10%+) holder in the Company and who has nominated a director to the board of the Company pursuant to a relevant agreement which gives them a right or expectation to do so;
(d) an Associate of a person referred to in (a) to (c) above; and
(e) a person whose relationship with the Company or a person referred to in (a) to (d) above is such that, in the ASX's opinion, the issue or agreement should be approved by Shareholders.

As Messrs Richard Jenkins, Christopher Fong, Neil Macdonald and Mark Skipper are current directors of the Company, they are a related party for the purposes of Listing Rule 10.11. The proposed issue does not fall within any of the exceptions in Listing Rule 10.12 and therefore requires the approval of the Company's Shareholders under Listing Rule 10.11.

To this end, Resolutions 6, 7, 8 and 9 seek the required Shareholder approval to issue the CY26 Fee Shares to Messrs Richard Jenkins, Christopher Fong, Neil Macdonald and Mark Skipper under and for the purposes of Listing Rule 10.11.

If approval is obtained under Listing Rule 10.11, in accordance with Listing Rule 7.2 (exception 14), separate approval is not required under Listing Rule 7.1 and the issuance will not be included within the Company's 15% capacity.

If any of Resolution 6, 7, 8 and 9 are passed, the Company will be able to proceed with the proposed issue of CY26 Fee Shares in respect of the relevant director to whom that specific resolution applies.

If any of Resolutions 6, 7, 8 and 9 are not passed, the Company will not be able to proceed with the proposed issue of CY26 Fee Shares in respect of the relevant director to whom that specific resolution applies, and may have to consider other ways to remunerate Messrs Richard Jenkins, Christopher Fong, Neil Macdonald and Mark Skipper which are not as cost effective for the Company.

Chapter 2E of the Corporations Act

Chapter 2E of the Corporations Act prohibits the Company from giving a financial benefit to a related party of the Company unless either:

(a) the giving of the financial benefit falls within one of the exceptions to the provisions; or
(b) Shareholder approval under Chapter 2E of the Corporations Act is obtained prior to the giving of the financial benefit.

The proposed issue of CY26 Fee Shares constitutes the giving of a financial benefit.

A "related party" for the purposes of the Corporations Act and the Listing Rules is widely defined and includes a director of a public company, a spouse of a director of a public company or an entity controlled by a director of a public company. The definition of "related party" also includes a person whom there is reasonable grounds to believe will become a "related party" of a public company.

As Messrs Richard Jenkins, Christopher Fong, Neil Macdonald and Mark Skipper are current Directors of the Company, they are considered to be "related parties" of the Company. Therefore, the proposed issue of CY26 Fee Shares to the Directors (or their nominees) requires Shareholder approval under Chapter 2E of the Corporations Act and Listing Rule 10.11, unless the issue of SARs falls within one of the exceptions to the provisions.

For each director for whom the issue of CY26 Fee Shares were considered, the other non-conflicted Directors considered the proposed issue and formed the view that the giving of this financial benefit was reasonable remuneration, given the circumstances of the Company, and the responsibilities held by that Director in the Company.

In reaching this view, the following considerations were taken into account:

(a) CY26 Fee Shares do not represent an incentive, but reflect the actual Director fees owed to the Directors in accordance with their letters of appointment;
(b) the issue of CY26 Fee Shares is a cost effective and efficient method to remunerate the Directors for their services as Directors of the Company, as opposed to alternative forms of remuneration, such as additional payments of cash; and

(c) the issue of CY26 Fee Shares allows the Company to attract and maintain high quality professionals to the Board of the Company, without impacting the Company's cash reserves.

Accordingly, the Company considers that the issue of the CY26 Fee Shares to each of the directors falls within the "reasonable remuneration" exception as set out in section 211 of the Corporations Act and relies on this exception for the purposes of these Resolutions 6, 7, 8 and 9.

Shareholder approval under Chapter 2E of the Corporations Act is therefore not required for this issue.

Information Required by Listing Rule 10.13

The following information in relation to the issue of CY26 Fee Shares is provided to Shareholders for the purposes of Listing Rule 10.13:

Requirement	Detail
The name of the persons	a. Richard Jenkins (Resolution 6)
	b. Christopher Fong (Resolution 7)
	c. Neil Macdonald (Resolution 8)
	d. Mark Skipper (Resolution 9)
Which category in rules 10.11.1-10.11.5 the person falls within and why	Messrs Richard Jenkins, Christopher Fong, Neil Macdonald and Mark Skipper fall within the category set out in Listing Rule 10.11.1 as they are related parties of the Company by virtue of being Directors and should the CY26 Fee Shares be issued to a nominee of the director, the nominees fall within the category set out in Listing Rule 10.11.4 being an associate of the director.
If the securities are not fully paid ordinary shares, a summary of the material terms of the securities	Securities proposed to be issued are Fully Paid Ordinary Shares.
The date(s) which the securities will be issued (not more than 1 month after the date of this Meeting)	The CY26 Fee Shares will be issued no later than one (1) month of Shareholder approval being obtained by the Company (or otherwise, as determined by the ASX in the exercise of their discretion)
	It is anticipated the CY26 Fee Shares will be issued on one date.
The price or consideration of the securities	The CY26 Fee Shares will be offered for nil cash consideration.
	The deemed issue price of the CY26 Fee Shares will be A$0.003104 per share.
The purpose of the issue, including intended use of any funds raised	The CY26 Fee Shares are issued in lieu of cash Director fees for the period from 31 January 2026 until 31 December 2026 for Messrs Jenkins, Fong, Macdonald and Skipper.
	No funds will be raised from the issue of CY26 Fee Shares.
If the person is a director therefore a related party, or, an associate of a director, and the issue is intended to remunerate or incentivise the director, details of their current remuneration package	The current total remuneration package received by each Director is set out below:
	Director	Total Remuneration
	Richard Jenkins	A$150,000 per annum

If the securities are issued under an agreement, a summary of any other material terms of the agreement

Christopher Fong	A$50,000 per annum
Neil Macdonald	A$30,000 per annum
Mark Skipper	A$30,000 per annum

Note:
Directors fees are inclusive of superannuation.
There are no other material terms of the agreements other than those mentioned in the Notice.

Voting Exclusion

A voting exclusion applies to Resolutions 6, 7, 8 and 9 and is set out in the Voting Exclusion and Prohibition Statements.

Directors' Recommendation

The Directors note that this will be an effective way for the Company to preserve cash whilst appropriately remunerating Directors for their services.
The Directors (excluding Mr Jenkins) recommend a vote in favour of the Resolution 6.
The Directors (excluding Mr Fong) recommend a vote in favour of the Resolution 7.
The Directors (excluding Mr Macdonald) recommend a vote in favour of the Resolution 8.
The Directors (excluding Mr Skipper) recommend a vote in favour of the Resolution 9.

Chair's Intention

The Chair intends to vote all undirected proxies in favour of Resolutions 6, 7, 8 and 9.

Resolution 10 - Approval of Issue of Fully Paid Ordinary Shares in lieu of Salary to Russell Kennett, Chief Executive Officer of the Company

Resolution 10 seeks Shareholder approval to issue and allot a total of 9,664,949 Fully Paid Ordinary Shares at a deemed issue price of A$0.003104 per share to Russell Kennett, Chief Executive Officer of the Company, in lieu of the cash salary for the period from 31 January 2026 until 31 December 2026 (CY26 Salary Shares), as another mechanism to help the Company preserve cash and also assist in continuing to align the interests of the CEO with shareholders of the Company.

Accordingly, Resolution 10 seeks Shareholder approval to issue 9,664,949 CY26 Salary Shares at a deemed issue price of A$0.003104 per share to Russell Kennett, Chief Executive Officer of the Company.

If approved, this Resolution will fall within an exception to ASX Listing Rule 7.1, which will allow the Company to issue these without using the Company's 15% capacity under Listing Rule 7.1.

ASX Listing Rule 7.1

Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid ordinary securities it had on issue at the start of that period. An issue of equity securities that is approved by the Company's Shareholders under Listing Rule 7.1 will not use up the Company's 15% limit and therefore does not reduce the Company's capacity to issue further equity securities without Shareholder approval under Listing Rule 7.1.

The issue does not fall within any of these exceptions and exceeds the 15% limit in Listing Rule 7.1. It therefore requires the approval of the Company's Shareholders under Listing Rule 7.1.

To this end, Resolution 10 seeks Shareholder approval of the issue of the CY26 Salary Shares under and for the purposes of Listing Rule 7.1.

If Resolution 10 is passed, the issue of the CY26 Salary Shares will be excluded in calculating the Company's 15% limit in Listing Rule 7.1 to issue equity securities without Shareholder approval over the 12-month period following the date on which the CY26 Salary Shares are issued.

If Resolution 10 is not passed, the Company will not be able to proceed with the issue of the CY26 Salary Shares, and the value will be paid in cash by the Company.

Information Required by ASX Listing Rule 7.3

The following information is provided to Shareholders for the purposes of Listing Rule 7.3:

Requirement	Detail
The name of the person or basis upon which that person is selected	Russell Kennett
Chief Executive Officer
The number and class of securities	9,664,949 Fully Paid Ordinary Shares
If the securities are not fully paid ordinary shares, a summary of the material terms of the securities	Securities proposed to be issued are Fully Paid Ordinary Shares
The date(s) of issue	The CY26 Salary Shares will be issued within three (3) months of Shareholder approval being obtained by the Company (or otherwise, as determined by the ASX in the exercise of their discretion)
The price or consideration of each security	The CY26 Salary Shares will be offered for nil cash consideration.
The deemed issue price of the CY26 Salary Shares will be A$0.003104 per share.
The purpose of the issue including intended use of funds	The CY26 Salary Shares are issued in lieu of cash salary for the period from 31 January 2026 until 31 December 2026.
A summary of any other material terms of the agreement	There are no other material terms of the agreement other than those mentioned in this Notice.

Voting Exclusion

A voting exclusion applies to Resolution 10 and is set out in the Voting Exclusion and Prohibition Statements.

Directors' Recommendation

The Directors recommend a vote in favour of this Resolution.

Chair's Intention

The Chair intends to vote all undirected proxies in favour of Resolution 10.

Resolutions 11, 12, 13 and 14 – Issue of Incentive Securities to Related Parties

Resolutions 11, 12, 13 and 14 seek Shareholder approval to issue and allot Share Appreciation Rights (SARs) under the Employee Incentive Plan (Plan) to Messrs Richard Jenkins, Christopher Fong, Neil Macdonald and Mark Skipper (or their nominees), Directors of the Company.

Accordingly, the Company considers that the issue of the SARs is an appropriate mechanism to incentivise and remunerate the Directors for their services and further align the interests of the Directors with Shareholders of the Company.

Director and Related Party Approvals

Listing Rule 10.14

ASX Listing Rule 10.14 provides that a listed company must not permit any of the following persons to acquire securities under an employee incentive scheme unless it obtains the approval of its Shareholders:

(a) a director of the Company;
(b) an associate of a director of the Company; or
(c) a person whose relationship with the Company or a person referred to in Listing Rule 10.14.1 or 10.14.2 is such that, in ASX's opinion, the acquisition should be approved by the Company's shareholders.

As Messrs Richard Jenkins, Christopher Fong, Neil Macdonald and Mark Skipper are Directors of the Company, the proposed issue of SARs constitutes the acquisition of securities under an employee incentive scheme for the purposes of Listing Rule 10.14 and therefore requires the approval of the Company's Shareholders under Listing Rule 10.14.

To this end, Resolutions 11, 12, 13 and 14 seek the required Shareholder approval to issue the SARs to Messrs Richard Jenkins, Christopher Fong, Neil Macdonald and Mark Skipper under and for the purposes of Listing Rule 10.14.

If approval is obtained under Listing Rule 10.14 in accordance with Listing Rule 10.12 (exception 8), separate approval is not required under Listing Rule 10.11. Listing Rule 7.1 limits the amount of equity securities that a listed company can issue without the approval of its shareholders over any 12-month period to 15% of the fully paid ordinary securities it had on issue at the start of that period.

In accordance with Listing Rule 7.2 (exception 14), if Resolutions 11, 12, 13 and 14 are passed, the issue of SARs will be excluded in calculating the Company's 15% capacity to issue equity securities under Listing Rule 7.1 without Shareholder approval over the 12-month period following the issue date.

If any of Resolution 11, 12, 13 and 14 are passed, the Company will be able to proceed with the proposed issue of SARs in respect of the relevant director to whom that specific resolution applies.

If any of Resolutions 11, 12, 13 and 14 are not passed, the Company will not be able to proceed with the proposed issue of SARs in respect of the relevant director to whom that specific resolution applies, and may have to consider other ways to incentivise and remunerate Messrs Richard Jenkins, Christopher Fong, Neil Macdonald and Mark Skipper which are not as cost effective for the Company.

Chapter 2E of the Corporations Act

Chapter 2E of the Corporations Act prohibits the Company from giving a financial benefit to a related party of the Company unless either:

The proposed issue of SARs constitutes the giving of a financial benefit.

the Corporations Act and Listing Rule 10.14, unless the issue of SARs falls within one of the exceptions to the provisions.

For the proposed issue of SARs to Richard Jenkins, Executive Chair, the other non-conflicted Directors considered the proposed issue and formed the view that the giving of this financial benefit was reasonable remuneration, given the circumstances of the Company, the quantum of the SARs, the terms of the SARs and the responsibilities held by that Director in the Company.

In reaching this view, the following considerations were taken into account:

a) the Executive Chair has not been issued any incentive securities which have been designed to incentivise and retain directors since 2021;
b) the quantum reflects a modest grant when assessed against current market standards and/or practices of other ASX listed companies of a similar size and stage of development; and
c) incentives to attract and retain the services of Directors who have appropriate knowledge and expertise, whilst maintaining the Company's cash reserves.

Accordingly, the Company considers that the issue of the SARs to Mr Jenkins falls within the "reasonable remuneration" exception as set out in section 211 of the Corporations Act and relies on this exception for the purposes of Resolution 11.

For the proposed issue of SARs to Messrs Fong, Macdonald and Skipper, the non-conflicted Directors for each proposed issue considered the proposed issue and formed the view that the giving of this financial benefit was reasonable remuneration, given the circumstances of the Company, the quantum of the SARs, the terms of the SARs and the responsibilities held by that Director in the Company.

Notably, a proposed grant of 5,000,000 SARs assessed against the Company's recent trading in 2026 (between $0.002 and $0.005) reflected a potential value of between $10,000 and $25,000, which was considered to be modest in the circumstances.

Accordingly, the Company considers that the issue of the SARs to Messrs Fong, Macdonald and Skipper falls within the "reasonable remuneration" exception as set out in section 211 of the Corporations Act and relies on this exception for the purposes of Resolutions 12, 13 and 14.

Information Required by Listing Rule 10.15

The following information in relation to the issue of SARs is provided to Shareholders for the purposes of Listing Rule 10.15:

Requirement	Detail
The name of the persons	a. Richard Jenkins (Resolution 11)
b. Christopher Fong (Resolution 12)
c. Neil Macdonald (Resolution 13)
d. Mark Skipper (Resolution 14)
Which category in rules 10.14.1-10.14.3 the person falls within and why	Messrs Richard Jenkins, Christopher Fong, Neil Macdonald and Mark Skipper fall within the category set out in Listing Rule 10.14.1 as they are related parties of the Company by virtue of being Directors and should the SARs be issued to a nominee of the director, the nominees fall within the category set out in Listing Rule 10.14.2 being an associate of the director.
The number and class of each securities proposed to be issued	a. Richard Jenkins: 18,000,000 SARs
b. Christopher Fong: 5,000,000 SARs
c. Neil Macdonald: 5,000,000 SARs
d. Mark Skipper: 5,000,000 SARs

If the person is a director, details of their total remuneration package

The current total remuneration package received by each Director is set out below:

Director	Total Remuneration
Richard Jenkins	A$150,000 per annum
Christopher Fong	A$50,000 per annum
Neil Macdonald	A$30,000 per annum
Mark Skipper	A$30,000 per annum

Note:
Directors fees are inclusive of superannuation
Nil securities previously issued under employee incentive scheme.

The number of securities previously issued to the person under the scheme and average acquisition price paid

If the securities are not fully paid ordinary shares, a summary of the material terms, an explanation of why this security is used and the value attributed

The material terms of the SARs are as follows:
- Vesting Condition: Continuous employment or engagement for 1 year from the date the SARs are issued.
- Expiry Date: 2 years from the date the SARs are issued.
- Leaver Provisions: Standard good/bad leaver provisions apply, subject to the Board's discretion.

SARs are proposed to be issued as a non-cash incentive to retain directors, align their interests with those of shareholders, and assist in bringing their total remuneration in line with market benchmarks over time.

The date(s) securities will be issued to the person under the scheme (not later than 3 years after this AGM)

The SARs will be issued within 3 years from the date of this Meeting, if approved by Shareholders of the Company.

The price the securities will be issued

The SARs are being offered at nil consideration.

A summary of the material terms of the scheme

A summary of the material terms of the Plan is attached as Annexure A.

A summary of the material terms of any loan that will be made to the person in relation to the acquisition

No loan will be made to the persons in relation to the proposed issue of SARs.

Details of any securities issued under the Plan will be published in each annual report of the Company relating to a period in which securities have been issued, and that approval for the issue of securities was obtained under Listing Rule 10.14.

Any additional persons who become entitled to participate in the Plan after the resolution was approved and who were not named in the notice of meeting will not participate until approval is obtained under Listing Rule 10.14.

Voting Exclusion

A voting exclusion and prohibition applies to the Resolutions 11, 12, 13 and 14 and is set out in the Voting Exclusion and Prohibition Statements.

Directors' Recommendation

The Directors note that this will be an effective way for the Company to preserve cash whilst appropriately remunerating Directors for their services.

The Directors (excluding Mr Jenkins) recommend a vote in favour of the Resolution 11.

The Directors (excluding Mr Fong) recommend a vote in favour of the Resolution 12.

The Directors (excluding Mr Macdonald) recommend a vote in favour of the Resolution 13.

The Directors (excluding Mr Skipper) recommend a vote in favour of the Resolution 14.

Chair's Intention

The Chair intends to vote all undirected proxies in favour of the Resolutions 11, 12, 13 and 14.

Resolution 15 – Consolidation of Capital

Under section 254H of the Corporations Act, a Company may consolidate its shares if the consolidation is approved by an ordinary resolution of shareholders at a general meeting.

The Company proposes to consolidate its share capital through the consolidation of every 100 Shares into 1 Share (Share Consolidation).

The Share Consolidation ratio was determined so that the share price of the Company following implementation of the Share Consolidation would be approximately $0.20 per Share, based on the closing price of the Shares of $0.0020 on 20 April 2026 (the last Trading Day).

If the Share Consolidation is approved, it is expected that it will take effect on and from Tuesday, 26 May 2026.

Effect on Shareholders

As the Share Consolidation applies equally to all Shareholders, individual shareholdings will be reduced in the same ratio as the total number of Shares (subject only to the rounding of fractions). As such, the Share Consolidation will have no material effect on the percentage interest of each individual Shareholder.

Similarly, other than minor changes as a result of rounding, the aggregate value of each Shareholder's Shares (and the Company's market capitalisation) should not change as a result of the Share Consolidation alone (that is, assuming no other market movements or impacts occur).

Shareholders should note that the Share Consolidation, if approved, would also influence the Company's share price. The price per Share may increase proportionately to reflect the reduced number of Shares on issue (although this is not certain and may be impacted by market movements or other events).

As noted above in section above, the Company has chosen the ratio of 100:1 to achieve a price per Share of approximately $0.20.

If this Resolution is passed, the Share Consolidation will be implemented and binding upon all Shareholders, regardless of how (or if) they vote on the resolution.

Reasons for Share Consolidation

At the date of this Notice, the Company has a total of 1,785,113,821 Shares on issue. The Share Consolidation is expected to result in a more appropriate and effective capital structure for the Company and a more appealing share price to a wider range of investors.

The Board also considers the Share Consolidation will have the following benefits:

better market perception from investors who equate a low share price with the perception of a poorly performing company; and

interest from quality, long term institutional investors, equity funds and lending institutions who seek stability and long-term growth.

Following implementation of the Share Consolidation, the Company expects there will be 17,851,138 Shares on issue (rounded up to the nearest whole number for each holder and assuming no further share issues occur between the date of this Notice and the effective date for the Share Consolidation).

Treatment of Fractions

Where the consolidation of a Shareholder's Shares results in an entitlement to a fraction of a Share, the fraction will be rounded up to the next whole number of Shares.

Share Appreciation Rights

At the date of this Notice, the Company has 97,500,000 Share Appreciation Rights on issue.

Listing Rule 7.21 provides that a listed entity which has convertible securities (except options) on issue may only recognise its capital, in respect of the convertible securities, the number of its convertible securities or the conversion price, or both, is reorganised so that the holder of the convertible securities will not receive a benefit that holders of ordinary securities do not receive. This rule does not prevent a rounding up of the number of securities to be received on conversion if the rounding up is approved at the shareholders' meeting which approves the reorganisation.

Accordingly, if this Resolution is passed, the SARs will also be consolidated on a 100:1 basis, and the applicable exercise price will be revised upwards in inverse proportion to that ratio.

The following table sets out the number of SARs that will be on issue and their applicable exercise price if the Share Consolidation is implemented:

Security	Number currently on issue	Exercise price currently	Number after consolidation	Exercise price after consolidation
SARs	97,500,000	$0.00	975,000	$0.00

Timetable

An indicative timetable, assuming Shareholder approval is obtained will be as follows:

Event	Date
The Company to announce the consolidation of capital via Appendix 3A.3	Monday, 25 May 2026
Effective date of the consolidation of capital	Tuesday, 26 May 2026
Last day for trading in pre-consolidation basis	Wednesday, 27 May 2026
Trading in post-consolidation on a deferred settlement basis	Thursday, 28 May 2026
Record date for consolidation
Last day to register transfers on a pre-consolidation basis	Friday, 29 May 2026
First day to update register, and send post-consolidation holding statements	Monday, 1 June 2026
Last day to update register, and send post-consolidation holding statements to Shareholders, announce to the ASX that this has occurred and trading on deferred settlement basis ends (if before noon Sydney time)	Friday, 5 June 2026

First day for normal trading on post-consolidation basis
Tuesday, 9 June 2026

Note: the dates above are indicative only and are subject to change.

Voting Exclusion
A voting exclusion does not apply to this resolution.

Directors' Recommendation
The Directors recommend a vote in favour of this Resolution.

Chair's Intention
The Chair intends to vote all undirected proxies in favour of the Resolution 15.

Enquiries
Shareholders are asked to contact the Company Secretary on [email protected] if they have any queries in respect of the matters set out in these documents.

Glossary

AEST means Australian Eastern Standard Time.

Annual Financial Report means the 2026 Annual Report to Shareholders for the period ended 31 December 2025 as lodged by the Company with ASX.

Annual General Meeting or AGM or Meeting means an Annual General Meeting of the Company and, unless otherwise indicated, means the meeting of the Company's members convened by this Notice of Meeting.

ASIC means Australian Securities and Investment Commission.

Associate has the meaning given to it by the ASX Listing Rules.

ASX means ASX Limited ACN 008 624 691 or the financial market operated by it, as the context requires, of 20 Bridge Street, Sydney, NSW 2000.

ASX Listing Rules or Listing Rules means the official ASX Listing Rules of the ASX and any other rules of the ASX which are applicable while the Company is admitted to the official list of the ASX, as amended or replaced from time to time, except to the extent of any express written waiver by the ASX.

Auditor's Report means the auditor's report of Stantons International Audit & Consulting Pty Ltd as included in the Annual Financial Report.

Board means the current board of Directors of the Company.

Business Day means a day on which trading takes place on the stock market of ASX.

Chair means the person chairing the Meeting.

Closely Related Party of a member of the KMP means:

(a) a spouse or child of the member;
(b) a child of the member's spouse;
(c) a dependant of the member or of the member's spouse;
(d) anyone else who is one of the member's family and may be expected to influence the member, or be influenced by the member, in the member's dealings with the Company;
(e) a company the member controls; or
(f) a person prescribed by the Corporation Regulations 2001 (Cth).

Company or Range International Limited means Range International Limited (ACN 611 998 200).

Constitution means the Company's constitution.

Corporations Act means the Corporations Act 2001 (Cth) as amended or replaced from time to time.

Director means a current director of the Company.

Directors' Report means the report of Directors as included in the Annual Financial Report.

Explanatory Statement means the explanatory statement accompanying this Notice of Meeting.

KMP means key management personnel (including the Directors) whose remuneration details are included in the Remuneration Report.

Notice of Meeting or Notice of Annual General Meeting means this notice of Annual General Meeting including the Explanatory Statement.

Ordinary Resolution means a resolution that can only be passed if at least 50% of the total votes cast by Shareholders entitled to vote on the resolution are voted in its favour at the meeting.

Proxy Form means the proxy form attached to this Notice of Meeting.

Remuneration Report means the remuneration report as set out in the Annual Financial Report.

Resolutions means the resolutions set out in this Notice of Meeting, or any one of them, as the context requires.

Restricted Voter means a member of the Company's KMP and any Closely Related Parties of those members.

Securities mean Shares and/or Options (as the context requires).

Share means a fully paid ordinary share in the capital of the Company.

Shareholder means a holder of a Share.

Share Registry means Automic Registry Services.

Special Resolution means a resolution that can only be passed if at least 75% of the total votes cast by Shareholders entitled to vote on the resolution are voted in its favour at the meeting.

Spill Meeting means the meeting that will be convened within 90 days of the 2027 AGM if a threshold of votes is cast against the adoption of the Remuneration Report at the Meeting.

Spill Resolution means the resolution required to be put to Shareholders at the 2027 AGM if a threshold of votes is cast against the adoption of the Remuneration Report at the Meeting.

Trading Day has the meaning given to that term in ASX Listing Rule 19.12.

VWAP means the volume weighted average market (closing) price, with respects to the price of Shares.

Annexure A – Summary of the material terms of the Plan

Purpose and Objects

1.1 The Plan is designed to:

a) reward, retain and motivate Eligible Participants;
b) link Participant rewards to creation of shareholder value; and
c) align the interests of key personnel with those of Range International Limited (Company) shareholders by granting equity-based incentives.

Eligible Participants

"Eligible Participants" are employees, directors and contractors of the Company or its subsidiaries whom the Board determines are eligible to participate from time to time.

Securities Offered & Dilution Cap

3.1 The Plan permits the grant of:

a) Performance Rights;
b) Options;
c) Share Appreciation Rights; and
d) fully paid ordinary Plan Shares issued on exercise or automatic vesting of the above
(together, Securities)

3.2 Grants under the Incentive Plan and any other employee incentive scheme in the preceding three-year period must not exceed 5% of the Company's issued share capital at the time of the proposed offer (Dilution Limit).

Invitation and Grant Process

4.1 The Board (or a duly-authorised committee) may invite Eligible Participants to apply for Securities on terms it determines, including number, grant price (if any), exercise price (if any) and applicable Vesting Conditions.

4.2 Invitations are made pursuant to Division 1A of Part 7.12 of the Corporations Act.

4.3 Securities are granted upon receipt and acceptance of the prescribed application documentation. Certificates (or holding statements) are issued following grant.

Vesting and Exercise

5.1 Convertible Securities (Options, Performance Rights and Share Appreciation Rights) vest when the Board issues a Vesting Notice confirming satisfaction (or waiver) of any time-based or performance hurdles.

5.2 Upon vesting, a Participant may exercise the Security by lodging a Notice of Exercise and paying any applicable exercise price, subject to "cashless exercise" being available at the Board's discretion.

5.3 Convertible Securities that are not exercised by the earlier of the expiry date or any lapse event automatically forfeit.

Forfeiture and Leaver Treatment

6.1 Unless the Board determines otherwise, all unvested Convertible Securities lapse where the Participant:
a) ceases employment or engagement (other than death or serious disability); or
b) engages in fraudulent, dishonest, gross-misconduct or other proscribed behaviour.

6.2 The Board retains overriding discretion to treat the Participant as a Good Leaver and permit vesting of some or all Securities.

Change of Control and Reorganisation

7.1 On a Change of Control Event (including successful takeover or scheme of arrangement), the Board may determine how outstanding Securities will be dealt with, including acceleration of vesting or cancellation for consideration.

7.2 Securities are subject to the usual capital-reorganisation adjustments required by Listing Rule 6.22.2.

Restrictions on Dealing, Hedging and Clawback

8.1 Unvested or restricted Securities cannot be sold, transferred, encumbered, hedged or otherwise dealt with; any unauthorised dealing causes automatic forfeiture.

8.2 The Board may impose holding locks or use an employee share trust to enforce statutory or policy-based disposal restrictions.

8.3 A Board-approved Clawback Policy may result in lapse or repayment of Securities or Plan Shares where, for example, a participant acts fraudulently, or a material misstatement occurs.

Administration and Amendment

9.1 The Board administers the Incentive Plan and may exercise broad discretions, including delegation to a committee or trustee.

9.2 The Board may amend the Plan at any time, provided existing rights are not materially reduced without participant consent except to comply with law, correct manifest error, address adverse tax consequences or facilitate a trust.

Tax & Regulatory Framework

10.1 The Plan is intended to qualify as a tax-deferred scheme under Subdivision 83A-C of the Income Tax Assessment Act 1997.

10.2 Offers rely on the employee share scheme provisions in the Corporations Act and on ASX Listing Rule 7.2, Exception 13(b) for placement capacity relief.

10.3 Where directors or related parties participate, separate shareholder approval will be sought under Listing Rule 10.14 and, if applicable, Corporations Act s200B/E termination-benefit limits.

Important Notice

This Annexure is a concise summary of the key terms of the Range International Limited Employee Securities Incentive Plan. It is not exhaustive and does not replace or supersede the full Plan Rules. Shareholders may inspect the complete Rules at the Company's registered office during normal business hours or request a copy from the Company Secretary.

RANGE

INTERNATIONAL

Poxy Voting Form

If you are attending the Meeting in person, please bring this with you for Securityholder registration.

Range International Limited | ABN 22 611 998 200

Your proxy voting instruction must be received by 11:30am (AEST) on Saturday, 23 May 2026, being not later than 48 hours before the commencement of the Meeting. Any Proxy Voting instructions received after that time will not be valid for the scheduled Meeting.

SUBMIT YOUR PROXY

Complete the form overleaf in accordance with the instructions set out below.

YOUR NAME AND ADDRESS

The name and address shown above is as it appears on the Company's share register. If this information is incorrect, and you have an Issuer Sponsored holding, you can update your address through the investor portal: https://investor.automic.com.au/#/home Shareholders sponsored by a broker should advise their broker of any changes.

STEP 1 - APPOINT A PROXY

If you wish to appoint someone other than the Chair of the Meeting as your proxy, please write the name of that Individual or body corporate. A proxy need not be a Shareholder of the Company. Otherwise if you leave this box blank, the Chair of the Meeting will be appointed as your proxy by default.

DEFAULT TO THE CHAIR OF THE MEETING

Any directed proxies that are not voted on a poll at the Meeting will default to the Chair of the Meeting, who is required to vote these proxies as directed. Any undirected proxies that default to the Chair of the Meeting will be voted according to the instructions set out in this Proxy Voting Form, including where the Resolutions are connected directly or indirectly with the remuneration of Key Management Personnel.

STEP 2 - VOTES ON ITEMS OF BUSINESS

You may direct your proxy how to vote by marking one of the boxes opposite each item of business. All your shares will be voted in accordance with such a direction unless you indicate only a portion of voting rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may vote as he or she chooses. If you mark more than one box on an item your vote on that item will be invalid.

APPOINTMENT OF SECOND PROXY

You may appoint up to two proxies. If you appoint two proxies, you should complete two separate Proxy Voting Forms and specify the percentage or number each proxy may exercise. If you do not specify a percentage or number, each proxy may exercise half the votes. You must return both Proxy Voting Forms together. If you require an additional Proxy Voting Form, contact Automic Registry Services.

SIGNING INSTRUCTIONS

Individual: Where the holding is in one name, the Shareholder must sign.

Joint holding: Where the holding is in more than one name, all Shareholders should sign.

Power of attorney: If you have not already lodged the power of attorney with the registry, please attach a certified photocopy of the power of attorney to this Proxy Voting Form when you return it.

Companies: To be signed in accordance with your Constitution. Please sign in the appropriate box which indicates the office held by you.

Email Address: Please provide your email address in the space provided.

By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible) such as a Notice of Meeting, Proxy Voting Form and Annual Report via email.

CORPORATE REPRESENTATIVES

If a representative of the corporation is to attend the Meeting the appropriate 'Appointment of Corporate Representative' should be produced prior to admission. A form may be obtained from the Company's share registry online at https://automicgroup.com.au.

Lodging your Proxy Voting Form:

Online

Use your computer or smartphone to appoint a proxy at

https://investor.automic.com.au/#/loginsah or

scan the QR code below using your smartphone

BY MAIL:

Automic

GPO Box 5193

Sydney NSW 2001

IN PERSON:

Automic

Level 5, 126 Phillip Street

Sydney NSW 2000

BY EMAIL:

[email protected]

BY FACSIMILE:

+61 2 8583 3040

All enquiries to Automic:

WEBSITE:

https://automicgroup.com.au

PHONE:

1300 288 664 (Within Australia)

+61 2 9698 5414 (Overseas)

RAN
AUTO MIC

STEP 1 - How to vote

APPOINT A PROXY:

I/We being a Shareholder entitled to attend and vote at the Annual General Meeting of Range International Limited, to be held at 11:30am (AEST) on Monday, 25 May 2026 at Level 5, 126 Phillip Street, Sydney, NSW 2000 hereby:

Appoint the Chair of the Meeting (Chair) to vote in accordance with the following directions (or if no directions have been given, and subject to the relevant laws, as the Chair sees fit) at this meeting and at any adjournment thereof.

Please note: If you are not appointing the Chair of the Meeting as your proxy, please write in the box provided below the name of the person or body corporate you are appointing as your proxy. If the person so named is absent from the meeting, or if no person is named, the Chair will act on your behalf.

The Chair intends to vote undirected proxies in favour of all Resolutions in which the Chair is entitled to vote.

Unless indicated otherwise by marking the "for", "against" or "abstain" box you will be authorising the Chair to vote in accordance with the Chair's voting intention.

AUTHORITY FOR CHAIR TO VOTE UNDIRECTED PROXIES ON REMUNERATION RELATED RESOLUTIONS

Where I/we have appointed the Chair as my/our proxy (or where the Chair becomes my/our proxy by default), I/we expressly authorise the Chair to exercise my/our proxy on Resolutions 1, 6, 7, 8, 9, 10, 11, 12, 13 and 14 (except where I/we have indicated a different voting intention below) even though Resolutions 1, 6, 7, 8, 9, 10, 11, 12, 13 and 14 are connected directly or indirectly with the remuneration of a member of the Key Management Personnel, which includes the Chair.

STEP 2 - Your voting direction

Resolutions	For	Against	Abstain	Resolutions	For	Against	Abstain
1 Adoption of Remuneration Report	☐	☐	☐	9 Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Mark Skipper, Non-Executive Director of the Company	☐	☐	☐
2 Election of Mark Skipper as Director	☐	☐	☐	10 Approval of Issue of Fully Paid Ordinary Shares in lieu of Salary to Russell Kennett, Chief Executive Officer of the Company	☐	☐	☐
3 Re-election of Richard Jenkins as Director	☐	☐	☐	11 Approval of Issue of Incentive Securities to Richard Jenkins – Executive Chair of the Company, under the Employee Incentive Plan	☐	☐	☐
4 Re-election of Christopher Fong as Director	☐	☐	☐	12 Approval of Issue of Incentive Securities to Christopher Fong – Executive Director of the Company, under the Employee Incentive Plan	☐	☐	☐
5 ASX Listing Rule 7.1A Approval of Future Issue of Securities (Additional 10% Placement Capacity)	☐	☐	☐	13 Approval of Issue of Incentive Securities to Neil Macdonald – Non-Executive Director of the Company, under the Employee Incentive Plan	☐	☐	☐
6 Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Richard Jenkins, Executive Chair of the Company	☐	☐	☐	14 Approval of Issue of Incentive Securities to Mark Skipper – Non-Executive Director of the Company, under the Employee Incentive Plan	☐	☐	☐
7 Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Christopher Fong, Executive Director of the Company	☐	☐	☐	15 Consolidation of Capital	☐	☐	☐
8 Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Neil Macdonald, Non-Executive Director of the Company	☐	☐	☐

Please note: If you mark the abstain box for a particular Resolution, you are directing your proxy not to vote on that Resolution and your votes will not be counted in computing the required majority on a poll.

STEP 3 - Signatures and contact details

By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible).

AI assistant

RANGE INTERNATIONAL LIMITED — Proxy Solicitation & Information Statement 2026

65662_rns_2026-04-23_29bd936e-31d3-49d8-afe7-64f1a42c2c96.pdf

ASX Announcement

Notice of Annual General Meeting and Proxy Form

About Range International:

2026 Annual General Meeting

Notice of Meeting

Voting by Proxy

Shareholder queries in relation to the Meeting

Notice of

Annual General Meeting

Explanatory Statement | Proxy Form

Important Information for Shareholders about the Company's 2026 AGM

Venue and Voting Information

Your vote is important

Voting in person

Voting by proxy

Online

Questions to the Board and Management

Power of Attorney

Corporate Representatives

Financial Statements and Reports

Resolution 1 – Adoption of Remuneration Report

Resolution 2 – Election of Mark Skipper as Director

Resolution 3 – Re-election of Richard Jenkins as Director

Resolution 4 – Re-election of Christopher Fong as Director

Resolution 5 – ASX Listing Rule 7.1A Approval of Future Issue of Securities (Additional 10% Placement Capacity)

Resolutions 6 – 9: Issue of Fully Paid Ordinary Shares in lieu of Director Fees

Resolution 6 – Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Richard Jenkins, Executive Chair of the Company

Resolution 7 – Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Christopher Fong, Executive Director of the Company

Resolution 8 – Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Neil Macdonald, Non-Executive Director of the Company

Resolution 9 – Approval of Issue of Fully Paid Ordinary Shares in lieu of Director Fees to Mark Skipper, Non-Executive Director of the Company

Resolution 10 – Approval of Issue of Fully Paid Ordinary Shares in lieu of Salary to Russell Kennett, Chief Executive Officer of the Company

Resolutions 11–14: Issue of Incentive Securities to Related Parties

Resolution 11 - Approval of Issue of Incentive Securities to Richard Jenkins – Executive Chair of the Company, under the Employee Incentive Plan

Resolution 12 – Approval of Issue of Incentive Securities to Christopher Fong – Executive Director of the Company, under the Employee Incentive Plan

Resolution 13 – Approval of Issue of Incentive Securities to Neil Macdonald – Non-Executive Director of the Company, under the Employee Incentive Plan

Resolution 14 – Approval of Issue of Incentive Securities to Mark Skipper – Non-Executive Director of the Company, under the Employee Incentive Plan

Resolution 15 – Consolidation of Capital

Voting Exclusion Statement

Voting Exclusion Statement

Voting Exclusion Statement

Voting Prohibition Statement

Explanatory Statement

Basis of Securities Numbers

Business of the Meeting

Financial Statements and Reports

Written Questions to the Auditor

Resolution 1 - Adoption of Remuneration Report

Voting Exclusion

Directors' Recommendation

Chair's Intention

Resolution 2 - Election of Mark Skipper as Director

Biography of Mark Skipper

Resolution 3 – Re-election of Richard Jenkins as Director

Resolution 4 – Re-election of Christopher Fong as Director

Biography of Christopher Fong

Directors' Recommendation

Chair's Intention

Resolution 5 – ASX Listing Rule 7.1A Approval of Future Issue of Securities (Additional 10% Placement Capacity)

Information Required by ASX Listing Rule 7.3A

Period for which the approval will be valid

Notes:

Allocation policy for issues under Listing Rule 7.1A

Resolutions 6, 7, 8 and 9 – Issue of Fully Paid Ordinary Shares in lieu of Director Fees

Listing Rule 10.11

Chapter 2E of the Corporations Act

Voting Exclusion

Directors' Recommendation

Chair's Intention

Resolution 10 - Approval of Issue of Fully Paid Ordinary Shares in lieu of Salary to Russell Kennett, Chief Executive Officer of the Company

ASX Listing Rule 7.1

Director and Related Party Approvals

Listing Rule 10.14

Chapter 2E of the Corporations Act

Voting Exclusion

Directors' Recommendation

Chair's Intention

Resolution 15 – Consolidation of Capital

RANGE INTERNATIONAL LIMITED Proxy Solicitation & Information Statement 2026